FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Strides Pharma Prednisone Tablets Recall

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Phar…

Strides Pharma Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Aug 17, 2022
Recall ID
D-1330-2022
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Prednisone Tablets starting Jul 19, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1330-2022 on Aug 17, 2022. Reason: Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets. Status: Terminated.

Why it was recalled

Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets

Product description

Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.

Lot numbers, UPCs & expiration codes

Lot #: 7248988B, Exp 9/2023

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1330-2022
Classification
Class II
Status
Terminated
Recall initiated
Jul 19, 2022
FDA report date
Aug 17, 2022
Quantity
1032 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-1330-2022, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
90634
Address
2 Tower Center Blvd Ste 1102
Code information
Lot #: 7248988B, Exp 9/2023
Postal code
08816-1100
Report date
Aug 17, 2022
Product type
Drugs
Recall number
D-1330-2022
Classification
Class II
Recalling firm
Strides Pharma Inc.
Product quantity
1032 bottles
Termination date
Jun 21, 2023
Reason for recall
Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
Voluntary / mandated
Voluntary: Firm initiated
Product description
Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd., Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-785-06.
Distribution pattern
US Nationwide
Recall initiation date
Jul 19, 2022
Initial firm notification
Letter
Center classification date
Aug 9, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1330-2022, published Aug 17, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls